Humana医疗公司报告收入丰厚, 但市场仍给予谨慎的“稳住”评级。 Healthcare firm Humana reported strong earnings, but market still gives cautious "Hold" rating.

保健公司Humana Inc.从23家研究公司获得“old”共识评级,12个月的价格目标是280.76美元。 Healthcare company Humana Inc. received a "Hold" consensus rating from 23 research firms, with a 12-month price target of $280.76. 该公司报告有一个强劲的季度,每股收入为11.58美元,超过分析师估计的1.51美元。 The company reported a strong quarter, with earnings per share of $11.58, surpassing analyst estimates by $1.51. 尽管华尔街Zen的“Buy”评级提升至“Buy”评级,但总体市场观点仍然谨慎。 Despite an upgrade to a "Buy" rating by Wall Street Zen, the overall market view remains cautious. Humana的市场资本化为291.8亿美元,P/E比率为17.10美元,股票交易额约为241.82美元。 Humana has a market capitalization of $29.18 billion and a P/E ratio of 17.10, with the stock trading around $241.82.